Data reinforce that mast cells are important drivers of CSU regardless of the underlying endotype and are consistent with the novel mechanism of action of barzolvolimab. Barzolvolimab is a promising ...
TipRanks on MSN
Celldex announces new barzolvolimab data at EADV congress
Celldex (CLDX) announced new data demonstrating rapid and strong efficacy regardless of baseline immunoglobulin E levels in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback